PharmaCyte Biotech, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
PharmaCyte Biotech, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • PharmaCyte Biotech, Inc. Return On Assets for the quarter ending July 31, 2024 was 38.4 %.
  • PharmaCyte Biotech, Inc. annual Return On Assets for 2023 was 0.42 %.
  • PharmaCyte Biotech, Inc. annual Return On Assets for 2022 was -6.13 %, a 88.4% increase from 2021.
  • PharmaCyte Biotech, Inc. annual Return On Assets for 2021 was -52.9 %, a 16.4% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 0.42 +6.55 May 1, 2023 Apr 30, 2024
2022 -6.13 +46.8 +88.4% May 1, 2022 Apr 30, 2023
2021 -52.9 +10.4 +16.4% May 1, 2021 Apr 30, 2022
2020 -63.3 -1.47 -2.38% May 1, 2020 Apr 30, 2021
2019 -61.8 -8.6 -16.2% May 1, 2019 Apr 30, 2020
2018 -53.2 +36.2 +40.5% May 1, 2018 Apr 30, 2019
2017 -89.5 -34.1 -61.7% May 1, 2017 Apr 30, 2018
2016 -55.3 +23.5 +29.8% May 1, 2016 Apr 30, 2017
2015 -78.8 +94.1 +54.4% May 1, 2015 Apr 30, 2016
2014 -173 +931 +84.3% May 1, 2014 Apr 30, 2015
2013 -1.1K -1.02K -1152% May 1, 2013 Apr 30, 2014
2012 -88.1 May 1, 2012 Apr 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.